Literature DB >> 11819743

A comparative study on serologic profiles of virus hepatitis B.

J N Fang1, C J Jin, L H Cui, Z Y Quan, B Y Choi, M Ki, H B Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11819743      PMCID： PMC4688684          DOI： 10.3748/wjg.v7.i1.107

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  5 in total

1.  [Seroepidemiological study of HBV infection in Hunan area].

Authors:  Y J Xiao
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1990-06

2.  [The prevalence of HBV in rural areas of Hebei Province. Viral Hepatitides Investigation Group of Zhengding County, Hebei Province].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1987-04

3.  [Seroepidemiologic study of viral hepatitis B in a suburb of Beijing].

Authors:  H T Wang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1985-06

4.  Interpretation of various serological profiles of hepatitis B virus infection.

Authors:  I K Mushahwar; J L Dienstag; H F Polesky; L C McGrath; R H Decker; L R Overby
Journal:  Am J Clin Pathol       Date:  1981-12       Impact factor: 2.493

Review 5.  Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization.

Authors:  J E Maynard; M A Kane; S C Hadler
Journal:  Rev Infect Dis       Date:  1989 May-Jun
  5 in total
  10 in total

1.  High frequencies of HGV and TTV infections in blood donors in Hangzhou.

Authors:  J Yan; L L Chen; Y H Luo; Y F Mao; M He
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine.

Authors:  Xiao-Ju Guan; Xiao-Jun Guan; Yu-Zhang Wu; Zheng-Cai Jia; Tong-Dong Shi; Yan Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  Effects of hepatitis B virus infection on human sperm chromosomes.

Authors:  Jian-Min Huang; Tian-Hua Huang; Huan-Ying Qiu; Xiao-Wu Fang; Tian-Gang Zhuang; Hong-Xi Liu; Yong-Hua Wang; Li-Zhi Deng; Jie-Wen Qiu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.

Authors:  Yanwen Jin; Cheng Cao; Ping Li; Xuan Liu; Wei Huang; Chufang Li; Qingjun Ma
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

6.  Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.

Authors:  Jun Wei; Yu-Qin Wang; Zhi-Meng Lu; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.

Authors:  Chao Lou; Zhi-Nan Chen; Hui-Jie Bian; Jie Li; Shou-Bo Zhou
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

8.  Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells via a self-modulating mechanism.

Authors:  Quan-Cheng Kan; Zu-Jiang Yu; Yan-Chang Lei; Lian-Jie Hao; Dong-Liang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.

Authors:  De-Wei Du; Zhan-Sheng Jia; Guang-Yu Li; Yong-Ying Zhou
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

10.  Improving health Professional's knowledge of hepatitis B using cartoon based learning tools: a retrospective analysis of pre and post tests.

Authors:  Moira G Sim; Ashleigh C McEvoy; Toni D Wain; Eric L Khong
Journal:  BMC Med Educ       Date:  2014-11-21       Impact factor: 2.463
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.